COMPARING EFFICACY OF GUSELKUMAB VERSUS USTEKINUMAB IN MODERATE TO SEVERE PSORIASIS PATIENTS : AN ADJUSTED COMPARISON BASED ON VOYAGE 1&2 AND NAVIGATE TRIALS

被引：0
|
作者：
Diels, J. [1 ]
Thilakarathne, P. [1 ]
Schubert, A. [2 ]
McElligott, S. [3 ]
机构：
[1] Janssen Cilag, Beerse, Belgium
[2] Janssen Cilag Poland, Warsaw, Poland
[3] Janssen Sci Affairs LLC, Horsham, PA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.830
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY4
引用
收藏
页码：A544 / A545
页数：2
相关论文
共 50 条
  • [11] Malignancy rates and comparisons to the general US population through 3 years in guselkumab-treated moderate-to-severe psoriasis patients in VOYAGE 1&2
    Papp, K. A.
    Reich, K.
    Gordon, K. B.
    Lebwohl, M.
    Song, M.
    Ramachandran, P.
    Randazzo, B.
    Shen, Y. -K.
    Blauvelt, A.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 102 - 102
  • [12] Efficacy responses across disease severity and treatment history subgroups of patients with moderate to severe plaque psoriasis treated with guselkumab: Pooled results from VOYAGE 1&2 through 5 years
    Gordon, Kenneth B.
    Merola, Joseph F.
    Foley, Peter
    Choi, Olivia
    Chan, Daphne
    Miller, Megan
    You, Yin
    Shen, Yaung-Kaung
    Yang, Ya-Wen
    Blauvelt, Andrew
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB163 - AB163
  • [13] Characterization of super responders to guselkumab treatment in moderate-to-severe psoriasis: results from the VOYAGE 1 and 2 clinical trials
    Reich, K.
    Gordon, K. B.
    Strober, B.
    Langley, R. G.
    Song, M.
    Shen, Y-K
    You, Y.
    Foley, P.
    Blauvelt, A.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 55 - 56
  • [14] COMPARATIVE EFFICACY OF GUSELKUMAB AND TILDRAKIZUMAB IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: A MATCHING-ADJUSTED INDIRECT COMPARISON
    Van, Sanden S.
    Diels, J.
    Schubert, A.
    Barthelmes, J.
    VALUE IN HEALTH, 2020, 23 : S410 - S410
  • [15] Matching-adjusted indirect treatment comparison of guselkumab and ixekizumab in patients with moderate-to-severe psoriasis
    Varu, Abhishek
    Cameron, Chris
    Diels, Joris
    Hutton, Brian
    McElligott, Sean
    Schubert, Agata
    van Sanden, Suzy
    Villacorta, Reggie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB187 - AB187
  • [16] EFFICACY OF BRODALUMAB AND GUSELKUMAB IN PATIENTS WITH PLAQUE PSORIASIS WHO ARE INADEQUATE RESPONDERS TO USTEKINUMAB: A MATCHING ADJUSTED INDIRECT COMPARISON (MAIC)
    Borg, E.
    Faurby, M.
    Hampton, P. J.
    VALUE IN HEALTH, 2019, 22 : S406 - S406
  • [17] Comparable and consistent efficacy responses with up to 3 years of guselkumab treatment in patients with moderate-to-severe plaque psoriasis regardless of prior treatment: Pooled analysis from the VOYAGE 1 and VOYAGE 2 trials
    Gordon, K.
    Guenther, L.
    Pinter, A.
    Choe, Y. -B.
    Song, M.
    Li, S.
    Fakharzadeh, S.
    Shen, Y-K.
    Tsai, T-F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB185 - AB185
  • [18] Consistency of response (PASI 90 or 100 and IGA 0 or 0/1) in patients with moderate to severe psoriasis treated with guselkumab: Results from the VOYAGE 1 and 2 trials
    Gordon, Kenneth
    Menter, Alan
    Ferris, Laura
    Martorell, Antonio
    Kim, Byung Soo
    Song, Michael
    Wasfi, Yasmine
    You, Yin
    Shen, Yaung-Kaung
    Langley, Richard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB87 - AB87
  • [19] Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials
    Blauvelt, Andrew
    Lebwohl, Mark
    Langley, Richard G.
    Rowland, Katelyn
    Yang, Ya-Wen
    Chan, Daphne
    Miller, Megan
    You, Yin
    Yu, Jenny
    Thaci, Diamant
    Foley, Peter
    Papp, Kim A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (02) : 274 - 282
  • [20] The Impact of Treatment with Guselkumab on Skin-related Quality of Life in Male and Female Patients with Moderate to Severe Psoriasis: Results from the VOYAGE 1 and 2 Trials
    Armstrong, April
    Puig, Luis
    Papp, Kim A.
    Strauss, Marcie E.
    Yang, Ya-Wen
    Cheng, Ru-Fong
    Miller, Megan
    Murase, Jenny E.
    Fernandez-Penas, Pablo
    Han, Chenglong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB235 - AB235
12345